about
Inhibitory Receptors Beyond T Cell Exhaustion.Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival.Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanomaUsing global gene expression to discriminate thin melanomas with poor outcomes.Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy.Circulating Tumor Cells, DNA, and mRNA: Potential for Clinical Utility in Patients With Melanoma.Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progression.Tumor growth suppressive effect of IL-4 through p21-mediated activation of STAT6 in IL-4Rα overexpressed melanoma models.Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma.Targeting Melanoma with Cancer-Killing Viruses.Metastatic pathways in patients with cutaneous melanoma.Multispectral imaging for highly accurate analysis of tumour-infiltrating lymphocytes in primary melanoma.BRAF inhibitors: resistance and the promise of combination treatments for melanoma.
P2860
Q35783318-7A61CDB0-76CB-4DF7-8CCC-76FFCB848CC0Q36089397-44343F6D-1943-4ACE-95DA-B60E6DFC70C6Q36110293-44626ADA-C876-471A-932B-86D7AA29F7EEQ36280622-0A505392-3CB7-459A-ACEF-8A585015423DQ36356547-70438557-4C9E-4834-9E7D-3EDE6D6CEDDDQ36452245-FCCFEFAD-1D84-4315-9998-7F96DD278C52Q36823360-45B44FC8-F6A9-495C-9EFD-B76831D2DC3AQ37269038-EC16B959-DB79-43ED-9692-1B6382A7DE09Q37384738-15AFF99C-9472-49AD-83E2-3B2936838978Q38676416-172BB341-9CAD-44B6-A01A-F4B24EE98A3DQ39024316-BD338675-C403-4104-BF31-DC81F05377DEQ39443969-39320EEF-A6F3-45BC-A254-58813601BD9CQ47104481-D84F4B05-B247-4D8D-819F-F8DB3A5570B8
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Evaluating biomarkers in melanoma.
@ast
Evaluating biomarkers in melanoma.
@en
type
label
Evaluating biomarkers in melanoma.
@ast
Evaluating biomarkers in melanoma.
@en
prefLabel
Evaluating biomarkers in melanoma.
@ast
Evaluating biomarkers in melanoma.
@en
P2860
P356
P1476
Evaluating biomarkers in melanoma
@en
P2093
Panagiotis Karagiannis
Sophia N Karagiannis
P2860
P356
10.3389/FONC.2014.00383
P577
2014-01-01T00:00:00Z